Intriguingly, neither genetic nor pharmacological Usp22 inhibition had any effect on EZH2 mRNA expression in MC38, 4T1, and RM1 tumor cells (Supplemental Figure 7C), suggesting that Usp22 regulates EZH2 at the posttranscriptional level. Here, USP22 is linked to neoplasm.